EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Readability of Patient-Facing Information of Antibiotics Used in the WHO Short 6-Month and 9-Month All Oral Treatment for Drug-Resistant Tuberculosis

John E Moore, Beverley C Millar

Lung · 2024

DOI: 10.1007/s00408-024-00732-z ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Lung, 2024. Verfasst von John E Moore und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Sciences, Ulster University, Cromore Road, Coleraine, Northern Ireland, BT52 1SA, UK. je.moore1@ulster.ac.uk. Hauptthemen laut MEDLINE: Comprehension, Tuberculosis, Multidrug-Resistant, Patient Education as Topic, Antitubercular Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Readability of patient-facing information of oral antibiotics detailed in the WHO all oral short (6 months, 9 months) has not been described to date. The aim of this study was therefore to examine (i) how readable patient-facing TB antibiotic information is compared to readability reference standards and (ii) if there are differences in readability between high-incidence countries versus low-incidence countries.

Methods

Ten antibiotics, including bedaquiline, clofazimine, ethambutol, ethionamide, isoniazid, levofloxacin, linezolid, moxifloxacin, pretomanid, pyrazinamide, were investigated. TB antibiotic information sources were examined, consisting of 85 Patient Information Leaflets (PILs) and 40 antibiotic web resouces. Of these 85 PILs, 72 were taken from the National Medicines Regulator from six countries (3 TB high-incidence [Rwanda, Malaysia, South Africa] + 3 TB low-incidence [UK, Ireland, Malta] countries). Readability data was grouped into three categories, including (i) high TB-incidence countries ( n = 33 information sources), (ii) low TB-incidence countries ( n = 39 information sources) and (iii) web information ( n = 53). Readability was calculated using Readable software, to obtain four readability scores [(i) Flesch Reading Ease (FRE), (ii) Flesch-Kincaid Grade Level (FKGL), (iii) Gunning Fog Index and (iv) SMOG Index], as well as two text metrics [words/sentence, syllables/word].

Results

Mean readability scores of patient-facing TB antibiotic information for FRE and FKGL, were 47.4 ± 12.6 (sd) (target ≥ 60) and 9.2 ± 2.0 (target ≤ 8.0), respectively. There was no significant difference in readability between low incidence countries and web resources, but there was significantly poorer readability associated with PILs from high incidence countries versus low incidence countries (FRE; p = 0.0056: FKGL; p = 0.0095).

Conclusions

Readability of TB antibiotic PILs is poor. Improving readability of PILs should be an important objective when preparing patient-facing written materials, thereby improving patient health/treatment literacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ComprehensionTuberculosis, Multidrug-ResistantPatient Education as TopicAntitubercular AgentsHumansSouth AfricaAdministration, OralWorld Health OrganizationIrelandMalaysiaIncidencePamphletsAnti-Bacterial AgentsHealth Literacy

Stichwörter der Autor:innen

Antibiotic resistanceAntibioticsReadabilityTreatment literacyTuberculosis

Substanzen

Antitubercular AgentsAnti-Bacterial Agents

Autor:innen und Institutionen

  • School of Biomedical Sciences, Ulster University, Cromore Road, Coleraine, Northern Ireland, BT52 1SA, UK. je.moore1@ulster.ac.uk.
  • Laboratory for Disinfection and Pathogen Elimination Studies, Northern Ireland Public Health Laboratory, Belfast City Hospital, Lisburn Road, Belfast, Northern Ireland, BT9 7AD, UK. je.moore1@ulster.ac.uk.
  • School of Biomedical Sciences, Ulster University, Cromore Road, Coleraine, Northern Ireland, BT52 1SA, UK.
  • Laboratory for Disinfection and Pathogen Elimination Studies, Northern Ireland Public Health Laboratory, Belfast City Hospital, Lisburn Road, Belfast, Northern Ireland, BT9 7AD, UK.

Zitieren

APA

Moore, J. E., & Millar, B. C. (2024). Readability of Patient-Facing Information of Antibiotics Used in the WHO Short 6-Month and 9-Month All Oral Treatment for Drug-Resistant Tuberculosis. Lung. https://doi.org/10.1007/s00408-024-00732-z

Vancouver

Moore JE, Millar BC. Readability of Patient-Facing Information of Antibiotics Used in the WHO Short 6-Month and 9-Month All Oral Treatment for Drug-Resistant Tuberculosis. Lung. 2024. doi:10.1007/s00408-024-00732-z

BibTeX
@article{Moore2024,
  author = {Moore, John E and Millar, Beverley C},
  title = {Readability of Patient-Facing Information of Antibiotics Used in the WHO Short 6-Month and 9-Month All Oral Treatment for Drug-Resistant Tuberculosis},
  journal = {Lung},
  year = {2024},
  doi = {10.1007/s00408-024-00732-z}
}
Kostenlos starten →